2. Trophoblast differentiation

Trophoblast differentiation is governed by coordinated signaling, transcriptional, and epigenetic programs that regulate cytotrophoblast (CTB) progenitor maintenance and commitment toward syncytiotrophoblast (STB) and extravillous trophoblast (EVT) states. These mechanisms have been investigated using complementary human and mouse trophoblast stem-cell systems, human pluripotent stem-cell differentiation models, primary trophoblast cultures, organoids, and genetically manipulated mouse embryos. Although several regulatory pathways are shared, trophoblast lineage specification and differentiation are not fully conserved between species; in particular, the human EVT lineage has no direct one-to-one equivalent in the mouse.

Transcriptional specification and the Hippo/TEAD4 axis

In the mouse conceptus, differential Hippo pathway activity links cell position and intercellular contact to trophoblast specification. LATS-mediated phosphorylation restricts nuclear YAP in inner cells, whereas reduced Hippo pathway activity permits nuclear YAP interaction with TEAD4 in outer cells. TEAD4 activity is therefore associated with trophectoderm specification and activation of trophoblast-associated transcriptional programs, including Cdx2. GATA3 acts within the TEAD4-associated regulatory network and contributes, together with CDX2, to trophoblast specification and differentiation in the mouse. The ELF5-centered transcriptional network provides an additional layer of trophoblast stem-cell regulation. Changes in ELF5 abundance influence its interactions with transcriptional regulators including EOMES and TFAP2C and modify the balance between self-renewal- and differentiation-associated transcriptional programs.

In human trophoblast models, the regulatory relationships among TEAD4, CDX2, GATA3 and other lineage regulators are more complex and should not be assumed to reproduce the mouse hierarchy directly.

BMP signaling and human trophoblast commitment

BMP4 is widely used experimentally to induce trophoblast-associated differentiation from human pluripotent stem cells. BMP4 exposure activates trophoblast-associated transcriptional programs while suppressing pluripotency-associated states in several experimental systems. Studies of BMP4-directed differentiation have identified a ΔNp63-positive cytotrophoblast-like intermediate in some human pluripotent stem-cell models before subsequent trophoblast differentiation. A GATA2/3–TFAP2A/C transcriptional network has also been associated with acquisition and maintenance of trophoblast identity, while GATA3 contributes to trophoblast commitment in BMP4-based differentiation systems.

BMP4 responses are strongly influenced by simultaneous modulation of competing pathways. Human pluripotent stem-cell differentiation protocols have therefore incorporated inhibition of Activin/Nodal/TGF-β and FGF signaling to bias differentiation toward trophoblast-associated states. These conditions are experimental and system-dependent and should not be interpreted as a universal representation of physiological human trophoblast specification or differentiation.

Wnt/β-catenin signaling and trophoblast differentiation

Canonical Wnt/β-catenin signaling contributes to trophoblast stem-cell regulation and differentiation, but its effects are highly dependent on cellular state, developmental context, and experimental conditions. Experimental manipulation of Wnt signaling in human trophoblast models can modify proliferation, differentiation, migration, invasion, and expression of lineage-associated genes. These observations support a role for Wnt-dependent transcription in trophoblast differentiation and invasive phenotypes, but they do not establish Wnt activation as a single or universal determinant of EVT specification.

Wnt signaling should therefore be considered in conjunction with other lineage-regulatory mechanisms controlling cell adhesion, migration, extracellular-matrix interactions, and trophoblast differentiation state rather than as an isolated driver of EVT development.

Notch and TGF-β/SMAD signaling

Notch signaling has an experimentally established role in human trophoblast lineage development. NOTCH1 is associated with EVT development, and experimental manipulation of NOTCH1 signaling alters differentiation toward the extravillous lineage. NOTCH2 shows distinct expression patterns among first-trimester CTB subtypes, consistent with dynamic regulation of Notch-family signaling across trophoblast populations and differentiation states, although expression differences should not by themselves be interpreted as evidence of a specific functional role.

TGF-β signaling is similarly dependent on trophoblast subtype and developmental state. Experimental analyses of SMAD2/3 phosphorylation, localization, and expression demonstrate differential activation of canonical TGF-β signaling across first-trimester trophoblast populations. These findings support a context-dependent role for TGF-β/SMAD signaling in trophoblast differentiation rather than a uniform effect across all trophoblast populations.

Hypoxia/HIF signaling and EVT differentiation

Oxygen availability represents an experimentally manipulable environmental regulator of trophoblast differentiation. Reduced oxygen tension can direct primary human CTBs toward an EVT-associated phenotype, and this response is dependent, at least in part, on hypoxia-inducible factor signaling. Hypoxia-associated changes include alterations in cellular morphology, adhesion, and differentiation programs, linking the hypoxia/HIF/trophoblast axis to acquisition of EVT-associated characteristics. These observations indicate that oxygen-dependent signaling can modulate trophoblast differentiation, while the precise response remains dependent on oxygen concentration, developmental state, and experimental model.

Trophoblast stem-cell culture and directed differentiation

Human trophoblast stem cells provide an experimental system for investigating trophoblast self-renewal and lineage differentiation. Established human TSC culture systems incorporate epidermal growth factor signaling, canonical Wnt activation, inhibition of pathways that promote differentiation, and ROCK inhibition during appropriate culture procedures. In the established human TSC system, additional modulation of epigenetic state, including histone deacetylase inhibition, contributes to maintenance of the trophoblast stem-cell state.

Experimental pathway manipulation can involve CHIR99021 to stimulate canonical Wnt signaling, A83-01 or related inhibitors to suppress Activin/TGF-β signaling, EGF to support trophoblast stem-cell propagation, and Y-27632 to inhibit ROCK-dependent cellular stress during selected procedures. BMP4-based differentiation systems can additionally use pathway inhibitors such as A83-01 and, in specific experimental contexts, PD173074 to modulate competing TGF-β and FGF signals. These reagents represent components of distinct experimental systems and should not be interpreted as a single standardized trophoblast differentiation formulation.

Forskolin-mediated elevation of intracellular cAMP is used experimentally to promote trophoblast syncytialization and STB-associated phenotypes. In these systems, cellular fusion is accompanied by transcriptional and morphological changes associated with syncytiotrophoblast differentiation.

Mouse TSCs provide a complementary genetic model in which regulators such as TEAD4, GATA3, ELF5, EOMES, and TFAP2C can be manipulated directly to investigate trophoblast stemness, lineage specification, and differentiation. Findings from this model remain essential for defining causal transcriptional mechanisms but should be interpreted in the context of species-specific differences in trophoblast development.

Three-dimensional trophoblast organoids

Three-dimensional human trophoblast organoids provide a model in which CTB progenitor populations can be maintained and differentiated within an organized multicellular environment. Human trophoblast organoid systems reproduce important features of early placental trophoblast development and can generate differentiated trophoblast populations relevant to STB and, under appropriate experimental conditions, EVT biology.

Defined organoid culture systems can incorporate EGF, canonical Wnt pathway modulation, TGF-β pathway inhibition, and additional growth-factor or extracellular-matrix components to support trophoblast self-renewal and differentiation. Extracellular-matrix matrices provide structural support for three-dimensional organoid formation and epithelial organization. However, matrix composition and growth-factor availability can influence cell state and differentiation, making extracellular-matrix composition an important experimental variable.

Single-cell analysis and lineage resolution

Single-cell RNA sequencing provides high-resolution analysis of trophoblast heterogeneity that is not obtainable from bulk transcriptomic measurements. Single-cell transcriptomic and trajectory-inference approaches have identified transcriptionally distinct trophoblast states and enabled inference of developmental relationships among progenitor CTBs, differentiating CTBs, STB-associated populations, and EVT-associated populations. These approaches also facilitate comparison of primary placental tissue with trophoblast stem-cell and organoid models.

Trajectory inference and pseudotemporal analyses should nevertheless be interpreted as computational models of developmental relationships rather than direct experimental proof of lineage transitions. Complementary lineage-tracing, perturbation, functional, and temporal analyses are required to establish causal lineage relationships.

In mouse, genetic lineage manipulation and loss- or gain-of-function approaches provide complementary evidence for causal relationships between transcription-factor activity and trophoblast fate. Experimental manipulation of Tead4, Gata3, and Elf5, together with stem-cell differentiation and embryo analyses, has been used to distinguish regulators required for trophoblast identity from factors associated secondarily with differentiation.

Molecular and cellular validation

Validation of trophoblast differentiation generally requires concordant molecular, cellular, and functional measurements. KRT7/CK7 is widely used as a trophoblast-associated marker, although it is not uniquely specific to trophoblasts. CGB/hCG-associated expression is frequently assessed during STB differentiation and reflects trophoblast endocrine and syncytialization-associated programs rather than constituting an independent definitive marker of STB identity. HLA-G is commonly used to identify EVT-associated populations, particularly differentiated/invasive EVT, but should likewise be interpreted together with additional lineage markers and functional properties.

Immunofluorescence, immunohistochemistry, flow cytometry, quantitative RT-PCR, western blotting, and transcriptomic profiling provide complementary approaches for defining lineage-associated phenotypes. Functional analyses can further assess cellular fusion, migration, invasion, adhesion, and extracellular-matrix interactions, allowing molecular marker expression to be interpreted together with cellular phenotype.

For STB, syncytium formation and fusion-associated molecular changes are particularly informative, whereas EVT studies commonly incorporate migration and invasion assays together with HLA-G expression and additional EVT-associated markers. Combining molecular, morphological, and functional measurements is therefore preferable to assigning trophoblast identity on the basis of a single marker.

Integrated view of trophoblast differentiation

Collectively, experimental studies support a model in which trophoblast differentiation mechanisms arise from an interacting network of Hippo/TEAD4, BMP, Wnt/β-catenin, Notch, TGF-β/SMAD, and HIF-dependent signaling together with lineage-regulatory transcription factors including CDX2, GATA3, TEAD4, TFAP2C, and ELF5. The relative contribution of each pathway depends on species, developmental stage, cellular state, and experimental context. Their interactions regulate trophoblast stem-cell maintenance, lineage commitment, syncytiotrophoblast fusion, and extravillous trophoblast invasion, while contributing to the cellular programs underlying early placental development.